NTBLQ (Notable Labs) Other Financing: $-0.31 Mil (TTM As of Jun. 2024)


What is Notable Labs Other Financing?

Notable Labs NTBLQ -90.00% Other Financing is $-0.31 Mil as of Jun. 2024.

Notable Labs's Other Financing for the three months ended in Jun. 2024 was $-0.31 Mil.

Notable Labs's Other Financing for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.31 Mil.

Notable Labs Other Financing Historical Data

* Premium members only.

The historical data trend for Notable Labs's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Notable Labs Other Financing Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Other Financing
0.03 4.09 3.90

Notable Labs Quarterly Data
Dec21 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
Other Financing Get a 7-Day Free Trial 4.35 1.85 0.00 0.00 -0.31

Notable Labs Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $-0.31 Mil mean?
Notable Labs (NTBLQ) has a Other Financing of $-0.31 Mil as of Jun. 2024. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Notable Labs and its competitors.
Is Notable Labs' Other Financing too high?
Notable Labs' current Other Financing is $-0.31 Mil.
How does Notable Labs' Other Financing compare to VRTX and REGN?
Notable Labs' Other Financing of $-0.31 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Notable Labs and its competitors. Notable Labs's current Other Financing is $-0.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Notable Labs stock overvalued right now?
Notable Labs (NTBLQ) has a current Other Financing of $-0.31 Mil. The current Other Financing is $-0.31 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Notable Labs (NTBLQ), the current Other Financing is $-0.31 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Notable Labs Business Description

Address 320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.